論文・総説 - 宮﨑　泰成

1. Furusawa H, Shimada S, Sawada A, Tanaka K, Yamamoto K, Miyazaki Y. Composite Lymphoma after Treatment with Infliximab for Sarcoidosis and Ankylosing Spondylitis. Internal medicine (Tokyo, Japan). 2025.01; 64 (1): 129-132. ( PubMed, DOI )

2. Iijima Y, Furusawa H, Yamana T, Shibata S, Shirai T, Okamoto T, Tateishi T, Adachi T, Kirimura S, Miyazaki Y. Reevaluating diagnosis in interstitial lung disease with a second multidisciplinary discussion. Respiratory investigation. 2024.11; 62 (6): 1027-1033. ( PubMed, DOI )

3. Nakayama S, Yoshizawa A, Tsurutani J, Yoshimura K, Aoki G, Iwamoto T, Nagase H, Sugimoto N, Kobayashi K, Izumi S, Kato T, Miyazaki Y, Kurihara Y, Taira N, Aihara T, Kikawa Y, Mukai H. Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease (NOSIDE). Breast cancer (Tokyo, Japan). 2024.11; 32 (1): 177-185. ( PubMed, DOI )

4. Shimamura T, Furusawa H, Ejima M, Ozawa A, Adachi T, Tateishi U, Miyazaki Y. Clinical characteristics and prognostic factors for MPO-ANCA positive interstitial lung disease: A comparative study of ANCA associated vasculitis (AAV)-ILD and pulmonary limited vasculitis. Respiratory investigation. 2024.11; 63 (1): 1-6. ( PubMed, DOI )

5. Kondoh Y, Furukawa T, Hozumi H, Suda T, Egashira R, Jokoh T, Fukuoka J, Kuwana M, Teramachi R, Fujisawa T, Hasegawa Y, Ogura T, Miyazaki Y, Oyama S, Teramukai S, Horiguchi G, Naito A, Inoue Y, Ichikado K, Bando M, Tomioka H, Nishioka Y, Chiba H, Ebina M, Nakanishi Y, Satoh K, Shiratori Y, Hashimoto N, Ishii M. The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis. BMC pulmonary medicine. 2024.10; 24 (1): 511. ( PubMed, DOI )

6. Sumikawa H, Komiya K, Egashira R, Tominaga J, Ueno M, Fukuda T, Yamada D, Takei R, Kataoka K, Kimura T, Kondoh Y, Ejima M, Shimamura T, Tateishi T, Tomioka H, Miyazaki Y, Suda T, Johkoh T. Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Respiratory investigation. 2024.09; 62 (5): 798-803. ( PubMed, DOI )

7. Kubota Natsushi, Okamoto Tsukasa, Shimada Sho, Yamana Takashi, Iijima Yuki, Sakakibara Rie, Shibata Sho, Honda Takayuki, Mitsumura Takahiro, Shirai Tsuyoshi, Furusawa Haruhiko, Tateishi Tomoya, Adachi Takuya, Kirimura Susumu, Miyazaki Yasunari. Solitary Pure Ground-glass Opacity Suspected of Being the Initial Presentation of Nonfibrotic Hypersensitivity Pneumonitis Internal Medicine. 2024.09; 63 (18): 2543-2546. ( 医中誌 )

8. Bando M, Chiba H, Miyazaki Y, Suda T. Current challenges in the diagnosis and management of idiopathic pulmonary fibrosis in Japan. Respiratory investigation. 2024.09; 62 (5): 785-793. ( PubMed, DOI )

9. Okamoto T, Hanafusa M, Abe T, Shimamura T, Ito M, Wakai Y, Jinta T, Higa K, Kondoh Y, Okouchi Y, Okuda R, Bando M, Suda T, Tomioka H, Fujiwara T, Takase M, Yoshihara S, Odajima H, Miyazaki Y. Estimated prevalence and incidence of hypersensitivity pneumonitis in Japan. Allergology international : official journal of the Japanese Society of Allergology. 2024.08; 74 (1): 66-71. ( PubMed, DOI )

10. Kurihara Y, Honda T, Takemoto A, Seto K, Endo S, Tanimoto K, Kirimura S, Kobayashi M, Baba S, Nakashima Y, Wakejima R, Sakakibara R, Ishibashi H, Inazawa J, Tanaka T, Miyazaki Y, Okubo K. Immunohistochemistry of p53 surrogates TP53 mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinoma. JTCVS open. 2024.08; 20 183-193. ( PubMed, DOI )

11. Bando M, Homma S, Date H, Kishi K, Yamauchi H, Sakamoto S, Miyamoto A, Goto Y, Nakayama T, Azuma A, Kondoh Y, Johkoh T, Nishioka Y, Fukuoka J, Miyazaki Y, Yoshino I, Suda T, Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society. Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition. Respiratory investigation. 2024.05; 62 (3): 402-418. ( PubMed, DOI )

12. Omori T, Hanafusa M, Kondo N, Miyazaki Y, Okada S, Fujiwara T, Kuramochi J. Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan. Journal of thoracic disease. 2024.05; 16 (5): 3170-3180. ( PubMed, DOI )

13. Hanzawa S, Sugiura M, Nakae S, Masuo M, Morita H, Matsumoto K, Takeda K, Okumura K, Nakamura M, Ohno T, Miyazaki Y. The Prostaglandin D2 Receptor CRTH2 Contributes to Airway Hyperresponsiveness during Airway Inflammation Induced by Sensitization without an Adjuvant in Mice. International archives of allergy and immunology. 2024.04; 185 (8): 1-9. ( PubMed, DOI )

14. Shimada S, Yamaguchi T, Mikoshiba S, Sato K, Mitsumura T, Komori K, Yamana T, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Okamoto T, Furusawa H, Tateishi T, Miyazaki Y. Relapsing bronchopneumonia due to community-associated methicillin-resistant Staphylococcus aureus: a case report. BMC infectious diseases. 2024.04; 24 (1): 374. ( PubMed, DOI )

15. Kitano M, Honda T, Hikita E, Masuo M, Miyazaki Y, Kobayashi M. Delayed immune-related adverse events in long-responders of immunotherapy: a single-center experience. Asia-Pacific journal of clinical oncology. 2024.04; 20 (4): 463-471. ( PubMed, DOI )

16. Komatsuzaki Keiko, Kageshima Hiroki, Sekino Yuki, Suzuki Yasuhiro, Ugajin Tsukasa, Tamaoka Meiyo, Hanazawa Ryoichi, Hirakawa Akihiro, Miyazaki Yasunari. Local nasal immunotherapy with birch pollen-galactomannan conjugate-containing ointment in mice and humans Allergology International. 2024.04; 73 (2): 290-301. ( 医中誌 )

17. Isobe K, Nakamura Y, Sakamoto S, Tomii K, Takimoto T, Miyazaki Y, Matsumoto M, Sugino K, Ichikado K, Moriguchi S, Yamaguchi K, Baba T, Ozasa H, Igata F, Anabuki K, Homma S, Date H, Suda T, Kishi K. Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia. ERJ open research. 2024.03; 10 (2): ( PubMed, DOI )

18. Iijima Y, Ejima M, Yamana T, Sonoda S, Shibata S, Shirai T, Okamoto T, Furusawa H, Tateishi T, Adachi T, Mori M, Kirimura S, Anzai T, Takahashi K, Miyazaki Y. Assessment of clinical relevance of antigen improves diagnostic accuracy of hypersensitivity pneumonitis. BMC pulmonary medicine. 2024.02; 24 (1): 84. ( PubMed, DOI )

19. Kubota N, Okamoto T, Shimada S, Yamana T, Iijima Y, Sakakibara R, Shibata S, Honda T, Mitsumura T, Shirai T, Furusawa H, Tateishi T, Adachi T, Kirimura S, Miyazaki Y. A Case of Solitary Pure Ground-glass Opacity Suspected of Being the Initial Presentation of Nonfibrotic Hypersensitivity Pneumonitis. Internal medicine (Tokyo, Japan). 2024.02; 63 (18): 2543-2546. ( PubMed, DOI )

20. Mochizuki A, Shiraishi K, Honda T, Higashiyama RI, Sunami K, Matsuda M, Shimada Y, Miyazaki Y, Yoshida Y, Watanabe SI, Yatabe Y, Hamamoto R, Kohno T. Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2024.02; 19 (7): 984-994. ( PubMed, DOI )